Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.
作者信息
Olivo Robert E, Scialla Julia J
机构信息
Department of Medicine and.
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
出版信息
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):868-870. doi: 10.2215/CJN.04380417. Epub 2017 May 26.
Abstract
摘要
相似文献
1
Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.摆脱磷结合：指导治疗目标的试验
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):868-870. doi: 10.2215/CJN.04380417. Epub 2017 May 26.
2
Phosphate binding and the glyceraldehyde-3-phosphate dehydrogenase reaction.磷酸结合与3-磷酸甘油醛脱氢酶反应
J Biol Chem. 1953 Aug;203(2):545-62.
3
The binding of diphosphopyridine nucleotide by glyceraldehyde-3-phosphate dehydrogenase.甘油醛-3-磷酸脱氢酶与二磷酸吡啶核苷酸的结合
J Biol Chem. 1953 Aug;203(2):527-44.
4
The binding of inorganic phosphate to myosin in the presence of adenosine triphosphate.在三磷酸腺苷存在的情况下，无机磷酸与肌球蛋白的结合。
J Biol Chem. 1960 Nov;235:3174-6.
5
Coenzyme binding and the thiol groups of glyceraldehyde-3-phosphate dehydrogenase.辅酶结合与3-磷酸甘油醛脱氢酶的巯基
J Biol Chem. 1953 Aug;203(2):563-73.
6
The reactivity of the bound DPN of muscle triose phosphate dehydrogenase.肌肉磷酸丙糖脱氢酶结合的二磷酸吡啶核苷酸的反应活性
Biochim Biophys Acta. 1957 Apr;24(1):141-54. doi: 10.1016/0006-3002(57)90157-9.
7
The specific binding of pyridoxal 5'-phosphate to bovine plasma albumin.磷酸吡哆醛与牛血浆白蛋白的特异性结合。
J Biol Chem. 1962 Apr;237:1113-20.
8
The binding of diphosphopyridine nucleotide by yeast glyceraldehyde-3-phosphate dehydrogenase.酵母3-磷酸甘油醛脱氢酶与二磷酸吡啶核苷酸的结合
J Biol Chem. 1959 May;234(5):1286-92.
9
The binding of analogues of diphosphopyridine nucleotide by yeast glyceraldehyde-3-phosphate dehydrogenase.酵母甘油醛-3-磷酸脱氢酶与二磷酸吡啶核苷酸类似物的结合
J Biol Chem. 1959 May;234(5):1293-6.
10
引用本文的文献
1
Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.心血管疾病中的慢性肾脏病-矿物质和骨异常更新。
Semin Nephrol. 2018 Nov;38(6):542-558. doi: 10.1016/j.semnephrol.2018.08.001.
本文引用的文献
1
Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.终末期肾病试验中的两个磷酸盐靶点（TARGET）：一项随机对照试验。
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):965-973. doi: 10.2215/CJN.10941016. Epub 2017 May 26.
2
Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.不确定性与谦逊的教训——涉及高血压的临床试验
N Engl J Med. 2016 Nov 3;375(18):1756-1766. doi: 10.1056/NEJMra1510067.
3
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.慢性肾脏病成人患者中使用的磷结合剂：一项随机试验的网络荟萃分析。
Am J Kidney Dis. 2016 Nov;68(5):691-702. doi: 10.1053/j.ajkd.2016.05.015. Epub 2016 Jul 22.
4
Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.司维拉姆与钙基结合剂治疗慢性肾脏病高磷血症的比较：随机对照试验的荟萃分析
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):232-44. doi: 10.2215/CJN.06800615. Epub 2015 Dec 14.
5
Intracellular Phosphate Dynamics in Muscle Measured by Magnetic Resonance Spectroscopy during Hemodialysis.血液透析期间通过磁共振波谱测量肌肉中的细胞内磷酸盐动力学
J Am Soc Nephrol. 2016 Jul;27(7):2062-8. doi: 10.1681/ASN.2015050546. Epub 2015 Nov 11.
6
Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.药物对血清甲状旁腺激素、磷和钙水平的影响与 CKD 患者死亡率的关系：一项荟萃分析。
Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21.
7
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.维持性透析患者中，柠檬酸铁磷酸盐结合剂与矿物质代谢及炎症标志物：一项随机临床试验预设分析的结果
Am J Kidney Dis. 2015 Sep;66(3):479-88. doi: 10.1053/j.ajkd.2015.03.013. Epub 2015 May 7.
8
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.参加联邦医疗保险D部分的透析患者中与慢性肾脏病矿物质和骨异常相关药物的使用情况及费用
Am J Kidney Dis. 2014 Nov;64(5):770-80. doi: 10.1053/j.ajkd.2014.04.014. Epub 2014 May 13.
9
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.磷酸盐和成纤维细胞生长因子 23 在心血管疾病中的作用。
Nat Rev Nephrol. 2014 May;10(5):268-78. doi: 10.1038/nrneph.2014.49. Epub 2014 Apr 1.
10
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
Zotero 插件